In Silico Analysis and Molecular Docking Studies of Novel 6,7-dihydropyrano [2,3-d] pyrimidin-5-one Derivatives as Human Epidermal Growth Factor Receptor 2 (HER2) and Epidermal Growth Factor Receptor (EGFR) Inhibitors
He is a Principal Investigator at Cancer Biology & Experimental Therapeutics Theme,
School of Biomedical Sciences, CUHK. He is also the Principal Investigator at
Shenzhen Research Institute, CUHK at Shenzhen. He is actively involved in molecular
biology of pancreatic cancer and liver cancer. He is also an active reviewer of
multiple grant agencies and peer-reviewed journals.